Lynch Syndrome: Clinical Trials

6 trials for Lynch Syndrome, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 active not recruiting, 1 completed, 1 not yet recruiting, 1 recruiting. 6 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 16Active not recruiting 2, Completed 1, Not yet recruiting 1, Recruiting 1, Withdrawn 1
Phase 22Active not recruiting 1, Not yet recruiting 1

Follow Lynch Syndrome: new trials by email Literature Review of Lynch Syndrome trials Research Report on Lynch Syndrome

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Preventive Dendritic Cell Vaccination for Lynch Syndrome
DC vaccination - Lynch Syndrome
Phase 1 / Phase 2Not yet recruitingRadboud University Medical Center162026-10-012026-08-19
First in Human Pilot Study to Assess the Safety and Efficacy of Dendritic Cells Loaded With Frameshift Derived Neopeptides for the Prevention of Cancer in of Lynch Syndrome Carriers
Autologous Tolerogenic Dendritic cells - Lynch Syndrome
Phase 1RecruitingFundacion Clinic per a la Recerca Biomédica202025-09-042026-04-13
Cancer Preventive Vaccine Nous-209 for Lynch Syndrome Patients
Adenoviral Tumor-specific Neoantigen Priming Vaccine GAd-209-FSP, Biospecimen Collection, Endoscopic Biopsy - Colorectal Carcinoma, Lynch Syndrome
Phase 1 / Phase 2Active not recruitingNational Cancer Institute (NCI)452022-11-102026-03-03
Testing the Combination of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) in Children, Adolescent, and Young Adult Patients With Relapsed/Refractory Cancers That Have an Increased Number of Genetic Changes, The 3CI Study
Biospecimen Collection, Ipilimumab, Nivolumab - Constitutional Mismatch Repair Deficiency Syndrome, Hematopoietic and Lymphoid Cell Neoplasm
Phase 1WithdrawnNational Cancer Institute (NCI)2021-05-112026-06-10
Pembrolizumab in Treating Younger Patients With Recurrent, Progressive, or Refractory High-Grade Gliomas, Diffuse Intrinsic Pontine Gliomas, Hypermutated Brain Tumors, Ependymoma or Medulloblastoma
Biospecimen Collection, Conventional Magnetic Resonance Imaging, Diffusion Tensor Imaging - Constitutional Mismatch Repair Deficiency Syndrome, Lynch Syndrome
Phase 1Active not recruitingNational Cancer Institute (NCI)712015-06-032026-07-20
Naproxen in Preventing DNA Mismatch Repair Deficient Colorectal Cancer in Patients With Lynch Syndrome
Laboratory Biomarker Analysis, Naproxen, Placebo Administration - Lynch Syndrome
Phase 1CompletedNational Cancer Institute (NCI)812014-01-272021-01-25

Narrower conditions

Colorectal Neoplasms, Hereditary Nonpolyposis (6)  ·  Turcot syndrome (2)  ·  Brain Neoplasms (1)  ·  Central Nervous System Neoplasms (1)  ·  Colorectal Neoplasms (1)  ·  Diffuse Intrinsic Pontine Glioma (1)  ·  Ependymoma (1)  ·  Familial ependymoma (1)  ·  Glioma (1)  ·  Hematologic Neoplasms (1)  ·  Lymphoma (1)  ·  Medulloblastoma (1)  ·  Neuroblastoma (1)  ·  Xeroderma Pigmentosum (1)

Broader conditions

Colonic Diseases (6)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (6)  ·  DNA Repair-Deficiency Disorders (6)  ·  Digestive System Diseases (6)  ·  Digestive System Neoplasms (6)  ·  Gastrointestinal Diseases (6)  ·  Gastrointestinal Neoplasms (6)  ·  Genetic Diseases, Inborn (6)  ·  Intestinal Diseases (6)  ·  Intestinal Neoplasms (6)  ·  Metabolic Diseases (6)  ·  Neoplasms (6)  ·  Neoplasms by Site (6)  ·  Neoplastic Syndromes, Hereditary (6)  ·  Nutritional and Metabolic Diseases (6)

Interventions

Specimen Handling (3)  ·  Biopsy (1)  ·  CTLA-4 Antigen (1)  ·  Diffusion Tensor Imaging (1)  ·  Endoscopic Mucosal Resection (1)  ·  Endoscopy (1)  ·  Ipilimumab (1)  ·  Magnetic Resonance Spectroscopy (1)  ·  Naproxen (1)  ·  Nivolumab (1)  ·  pembrolizumab (1)

Sponsors

National Cancer Institute (NCI) (4)  ·  Fundacion Clinic per a la Recerca Biomédica (1)  ·  Radboud University Medical Center (1)

Countries

United States (4)  ·  Canada (2)  ·  Netherlands (1)  ·  Puerto Rico (1)  ·  Spain (1)

Top investigators

Eduardo Vilar-Sanchez (2)  ·  Daniel A Morgenstern (1)  ·  Eugene I Hwang (1)

Results publications

PMID 32641470, PMID 41545594

NIH funding

P30CA016672 (2), 2025 (1), N01CN00034 (1), P30CA015704 (1), UG1CA242609 (1), UM1CA081457 (1), UM1CA154967 (1)